[1]Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
[2]Liu X,Pan F,Ba Z,et al.The potential effectof type 2 diabetes mellitus on lumbar disc degeneration:A retrospective single-center study[J].Orthop Surg Res,2018,13(1):52.
[3]Kakadiya G,Gandbhir V,Soni Y,et al.Diabetes mellitus—A risk factor for the development of lumbar disc degeneration:A retrospective study of an indian population[J].Global Spine J,2022,12(2):215-220.
[4]Cannata F,Vadalà G,Ambrosio L,et al.Intervertebral disc degeneration:A focus on obesity and type 2 diabetes[J].Diabetes Metab Res Rev,2020,36(1):e3224.
[5]Song Y,Wang Y,Zhang Y,et al.Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells[J].J Cell Mol Med,2017,21(7):1373-1387.
[6]Luo R,Song Y,Liao Z,et al.Impaired calcium homeostasis via advanced glycation end products promotes apoptosis through endoplasmic reticulum stress in human nucleus pulposus cells and exacerbates intervertebral disc degeneration in rats[J].The FEBS Journal,2019,286(21):4356-4373.
[7]Kong CG,Park JB,Kim MS,et al.High glucose accelerates autophagy in adult rat intervertebral disc cells[J].Asian Spine J,2014,8(5):543-548.
[8]Chen D,Xia D,Pan Z,et al.Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo[J].Cell Death Dis,2016,7(10):e2441.
[9]Cabral-Pacheco GA,Garza-Veloz I,Castruita-De la Rosa C,et al.The roles of matrix metalloproteinases and their inhibitors in human diseases[J].Int J Mol Sci,2020,21(24):9739.
[10]Won HY,Park JB,Park EY,et al.Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats[J].J Neurosurg Spine,2009,11(6):741-748.
[11]Kaplan M,Arici L,Ozturk S,et al.A comparison of the type IX collagen levels of the intervertebral disc materials in diabetic and non-diabetic patients who treated with lumbar microdiscectomy[J].Eur Spine J,2018,27(1):214-221.
[12]Zhang Y,Si M,Li C,et al.Effect of hyperlipidaemia to accelerate intervertebral disc degeneration in the injured rat caudal disc model[J].J Orthop Sci,2019,24(1):42-49.
[13]张月东.血脂异常与椎间盘退变的相关性研究[D].济南:山东大学,2017.
[14]欧阳林,李瑾.腰椎体退变与血液供应减少相关:基于一项双期增强CT研究[J].中国骨质疏松杂志,2014,20(6):631-635;643.
[15]Fields AJ,BergJohansen B,Metz LN,et al.Alterations in intervertebral disc composition,matrix homeostasis and biomechanical behavior in the UCD-T2DM rat model of type 2 diabetes[J].J Orthop Res,2015,33(5):738-746.
[16]Fabiane SM,Ward KJ,Iatridis JC,et al.Does type 2 diabetes mellitus promote intervertebral disc degeneration[J].Eur Spine J,2016,25 (9):2716-2720.
[17]Samartzis D,Karppinen J,Chan D,et al.The association of lumbar intervertebral disc degeneration on magnetic resonance imaging with body mass index in overweight and obese adults:A populationbased study〖JP〗[J].Arthritis Rheum,2012,64(5):1488-1496.
[18]Dario AB,Ferreira ML,Refshauge KM,et al.The relationship between obesity,low back pain,and lumbar disc degeneration when genetics and the environment are considered:A systematic review of twin studies[J].Spine J,2015,15(5):1106-1117.
[19]Chen R,Liang X,Huang T,et al.Effects of type 1 diabetes mellitus on lumbar disc degeneration:A retrospective study of 118 patients[J].J Orthop Surg Res,2020,15(1):280.
[20]Russo F,Ambrosio L,Ngo K,et al.The role of type I diabetes in intervertebral disc degeneration[J].Spine (Phila Pa 1976),2019,44(17):1177-1185.
[21]Garg M,Thamotharan M,Becker DJ,et al.Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1 (GLUT1)[J].Pediatr Diabetes,2014,15(7):511-518.
[22]刘超.糖尿病对椎间盘和终板退变的影响临床观察和实验研究[D].杭州:浙江大学,2011.
[23]Ek塂i M塁,Kara M,zcan-Ek塂i EE,et al.Is diabetes mellitus a risk factor for modic changes?A novel model to understand the association between intervertebral disc degeneration and end-plate changes[J].J Orthop Sci,2020,25(4):571-575.
[24]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[25]Huang W,Han Z,Liu J,et al.Risk factors for recurrent lumbar disc herniation:A systematic review and meta-analysis[J].Medicine (Baltimore),2016,95(2):e2378.
[26]Wang H,Zhou Y,Li C,et al.Risk factors for failure of single-level percutaneous endoscopic lumbar discectomy[J].J Neurosurg Spine,2015,23(3):320-325.
[27]Yu C,Zhan X,Liu C,et al.Risk factors for recurrent L5S1 disc herniation after percutaneous endoscopic transforaminal discectomy:A retrospective study[J].Med Sci Monit,2020(26):e919888.
[28]Ma J,He Y,Wang A,et al.Risk factors analysis for foot drop associated with lumbar disc herniation:An analysis of 236 patients[J].World Neurosurg,2018(110):e1017e1024.
[29]Illien-Junger S,Torre OM,Kindschuh WF,et al.AGEs induce ectopic endochondral ossification in intervertebral discs[J].Eur Cell Mater,2016(32):257-270.
[30]Asadian L,Haddadi K,Aarabi M,et al.Diabetes mellitus,a new risk factor for lumbar spinal stenosis:A case-control study[J].Clin Med Insights Endocrinol Diabetes,2016(9):1-5.
[31]Cui G,Watanabe K,Miyauchi Y,et al.Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis patients with and without diabetes mellitus[J].J Orthop Sci,2011,16(6):785-790.
[32]Afsharian T,Azhari S,Mostafazadeh B.Comparison of postoperative clinical outcome after repairing surgery for lumbar spinal stenosis between diabetic and nondiabetic patients[J].Asian J Neurosurg,2017,12(3):424-427.
[33]Ying H,Luo ZW,Peng AF,et al.Incidences and reasons of postoperative surgical site infection after lumbar spinal surgery:A large population study[J].Eur Spine J,2022,31(2):482-488.
[34]Golinvaux NS,Varthi AG,Bohl DD,et al.Complication rates following elective lumbar fusion in patients with diabetes:Insulin dependence makes the difference[J].Spine (Phila Pa 1976),2014,39(21):1809-1816.
[35]潘丹,黄庆华,欧阳骁杰,等.腰椎后路术后切口脂肪液化相关危险因素分析[J].临床骨科杂志,2021,24(2):203-206.〖1〗
[36]Feinkohl I,Winterer G,Pischon T.Diabetes is associated with risk of postoperative cognitive dysfunction:A metaanalysis[J].Diabetes Metab Res Rev,2017,33(5):2884.
[37]Jung JM,Chung CK,Kim CH,et al.Prognosis of symptomatic pseudarthrosis observed at 1 year after lateral lumbar interbody fusion[J].Spine (Phila Pa 1976),2021,15;46(18):E1006-E1013.
[38]Moazzeni K,Kazemi KA,Khanmohammad R,et al.Comparison of surgical outcome between diabetic versus nondiabetic patients after lumbar fusion[J].Int J Spine Surg,2018,12(4):528-532.
[39]Takahashi S,Suzuki A,Toyoda H,et al.Characteristics of diabetes associated with poor improvements in clinical outcomes after lumbar spine surgery[J].Spine (Phila Pa 1976),2013,38(6):516-522.
[40]Canseco JA,Chang M,Karamian BA,et al.Postoperative glycemic variability as a predictor of adverse outcomes following lumbar fusion[J].Spine (Phila Pa 1976),2022,47(7):E304-E311.